197 related articles for article (PubMed ID: 3318403)
1. Comparison of two lymphokines (macrophage migration inhibition, leukocyte adherence inhibition factors) and carcinoembryonic antigen, in colorectal cancer and colonic premalignant lesions.
Shkolnik T; Livni E; Reshef R; Lachter J; Eidelman S
Am J Gastroenterol; 1987 Dec; 82(12):1275-8. PubMed ID: 3318403
[TBL] [Abstract][Full Text] [Related]
2. Tissue carcinoembryonic antigen, dysplasia, and disease duration in colonic inflammatory bowel disease.
Greenstein AJ; Panvelliwalla DK; Katz LB; Heimann TM; Donnelly J; Pertsimlidis D; Geller S; Smith H; Aufses AH
Am J Gastroenterol; 1982 Apr; 77(4):212-5. PubMed ID: 7072691
[TBL] [Abstract][Full Text] [Related]
3. Antitumor immune response to colorectal cancer antigen detected by the leukocyte adherence inhibition test (LAI) in groups at high risk for colorectal cancer.
Shani A; Fink A; Bass D; Gottesfeld F; Becker S; Levy E; Bentwich Z; Rozen P; Fireman Z; Hallak A
Cancer Detect Prev; 1986; 9(5-6):485-90. PubMed ID: 3779710
[TBL] [Abstract][Full Text] [Related]
4. [Leukocyte migration test and determination of carcinoembryonic antigens in the postoperative follow-up care of colon and rectum carcinoma].
Schulz U; Zoeller M; Matzku S
Chir Forum Exp Klin Forsch; 1978; (1978):221-5. PubMed ID: 752590
[TBL] [Abstract][Full Text] [Related]
5. A comparison between the macrophage migration inhibition test (MMI) and the leucocyte adherence inhibition test (LAI) in patients with melanoma and carcinoma of the colon.
Isbister WH
N Z Med J; 1978 Oct; 88(622):327-30. PubMed ID: 366475
[TBL] [Abstract][Full Text] [Related]
6. [Leukocyte adherence inhibition test and carcinoembryonic antigen in colorectal carcinoma].
Shani A; Weissman Z; Cohen Z; Amruch D; Cohen O; Nissim F; Shindel A; Sela A; Rosen A; Modan M; Bentwich Z
Harefuah; 1981 Nov; 101(10):241-3. PubMed ID: 6749609
[No Abstract] [Full Text] [Related]
7. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer.
De Carli HO; Restbergs V
Rev Esp Oncol; 1983; 30(1):25-39. PubMed ID: 6387830
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of malignant processes of the colon and rectum using a new method for the demonstration of sensitized lymphocytes (PAL-test)].
Bauer HW; Richter H; Schottler S; Ax W
Chir Forum Exp Klin Forsch; 1978; (1978):215-9. PubMed ID: 752589
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of the adherence of leukocytes labelled with Cr-51 in colorectal cancer].
Mounielou PM; Clemente F; Estival A; Ribet A
Gastroenterol Clin Biol; 1984 Oct; 8(10):736-41. PubMed ID: 6396147
[TBL] [Abstract][Full Text] [Related]
10. Postsurgical follow-up of colorectal cancer patients monitored by the leukocyte migration test.
Zöller M; Schulz U; Dietze W; Wesch H; Matzku S
J Natl Cancer Inst; 1983 Apr; 70(4):581-7. PubMed ID: 6572745
[TBL] [Abstract][Full Text] [Related]
11. Leucocyte adherence inhibition and carcinoembryonic antigen in combination for diagnosis of colorectal cancer.
Payne JE; Dent O; Chapuis PH; Meyer HJ; Sutherland MA; Ruwoldt A
J Surg Oncol; 1983 Mar; 22(3):212-5. PubMed ID: 6339824
[TBL] [Abstract][Full Text] [Related]
12. Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas.
Lee H; Rhee H; Kang HJ; Kim HS; Min BS; Kim NK; Kim H
Am J Clin Pathol; 2008 May; 129(5):772-9. PubMed ID: 18426738
[TBL] [Abstract][Full Text] [Related]
13. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
Wagner T; Peschel U; Heydrich D; Ritter U
Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
[TBL] [Abstract][Full Text] [Related]
14. Value of plasma alpha-1-acid glycoprotein assay in the detection of human colorectal cancer: comparison with carcinoembryonic antigen.
Chu CY; Lai LT; Pokala HP
J Natl Cancer Inst; 1982 Jan; 68(1):75-9. PubMed ID: 7033631
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen in colonic lavage.
Winawer SJ; Fleisher M; Green S; Bhargava D; Leidner SD; Boyle C; Sherlock P; Schwartz MK
Gastroenterology; 1977 Oct; 73(4 Pt 1):719-22. PubMed ID: 892376
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of colon cancer through measurement of carcinoembroyonic antigen levels, tests of cellular immune competence, and tumor specific immunity.
Holyoke ED; Goldrosen MH
Int Adv Surg Oncol; 1978; 1():85-111. PubMed ID: 399765
[No Abstract] [Full Text] [Related]
17. The use of carcinoembryonic antigen in the clinical management of patients with colorectal cancer.
Steele G; Zamcheck N
Cancer Detect Prev; 1985; 8(3):421-7. PubMed ID: 4064062
[TBL] [Abstract][Full Text] [Related]
18. [Significance of CEA and CA242 in the diagnosis of colorectal carcinoma].
Wu J; Yu H; Shao Y
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):438-40. PubMed ID: 8697997
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
20. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
